Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
Flowers
Franklin
F
Department of Otolarnygology, University of Florida, College of Medicine, Florida, USA.
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000287:Administration, Topical; D000634:Aminoquinolines / Q000627:therapeutic use*; D001913:Bowen's Disease / Q000188:drug therapy*; D002921:Cicatrix / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004890:Erythema / Q000139:chemically induced; D006801:Humans; D018327:Hutchinson's Melanotic Freckle / Q000188:drug therapy; D000077271:Imiquimod; D007642:Keratosis / Q000188:drug therapy*; D010145:Paget Disease, Extramammary / Q000188:drug therapy; D010778:Photochemotherapy; D011537:Pruritus / Q000139:chemically induced; D016032:Randomized Controlled Trials as Topic; D012878:Skin Neoplasms / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod